Cite
HARVARD Citation
Schwarz, T. et al. (n.d.). 119. Safety and Reactogenicity of an Investigational Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine for Adults ≥ 60 Years of Age (RSVPreF3 OA): an Interim Analysis at 6 Months after Vaccination. Open forum infectious diseases. p. . [Online].